Back to Journals » Infection and Drug Resistance » Volume 6

In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide

Authors Masadeh M, Mhaidat N, Alzoubi KH, Hussein EI, Al-Trad E

Received 12 December 2012

Accepted for publication 23 January 2013

Published 6 March 2013 Volume 2013:6 Pages 27—32

DOI https://doi.org/10.2147/IDR.S41501

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Majed M Masadeh,1 Nizar M Mhaidat,2 Karem H Alzoubi,2 Emad I Hussein,3 Esra’a I Al-Trad4

1Department of Pharmaceutical Technology, 2Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 3Department of Biological Sciences, Yarmouk University, Irbid, Jordan; 4Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan

Abstract: We carried out a comprehensive overview of inhibitory effects of selected antibiotics on planktonic and biofilm cells of Staphylococcus aureus (ATCC 29213) and Pseudomonas aeruginosa (ATCC 27853) strains. The possible involvement of protease activity and the lipopolysaccharide (LPS) profile of P. aeruginosa were also analyzed. Biofilm cells of both strains were more resistant to antibiotics than their planktonic counterparts. Protease activity was increased in both strains in the biofilm forms. Challenge with sublethal doses of antibiotics also increased proteolytic activity of biofilm cells. Additionally, the LPS profile of P. aeruginosa showed pattern alterations of the biofilm that can contribute to biofilm resistance and survival. These observations provide evidence for the involvement of bacterial proteolytic activity and LPS profile in the resistance of biofilm bacteria to antibiotics compared to their planktonic counterparts.

Keywords: biofilm, Pseudomonas aeruginosa, Staphylococcus aureus, proteolytic activity, lipopolysaccharide

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Investigation of the antibacterial activity of pioglitazone

Masadeh MM, Mhaidat NM, Al-Azzam SI, Alzoubi KH

Drug Design, Development and Therapy 2011, 5:421-425

Published Date: 27 September 2011